INFLIXIMAB TREATMENT FOR CHECKPOINT INHIBITOR INDUCED COLITIS: CLINICAL OUTCOMES FROM A MULTI-CENTRE STUDY

被引：0
|
作者：
Alexander, James L.
Sheth, Bhavisha
Ibraheim, Hajir
Little, Jessica
Khan, Muhammad S.
Richards, Camellia
Hunter, Nikki
Mchugh, Kathleen
Ratnakumaran, Raguprakash
Nathan, Paul
Choy, Julia
Crusz, Shanthini M.
Furness, Andrew
Turajlic, Samra
Pickering, Lisa
Larkin, James
Pinato, David
Papa, Sophie
Speight, Ally
Sharma, Anand
Powell, Nick
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
108
引用
收藏
页码：S26 / S27
页数：2
相关论文
共 50 条
  • [21] Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab
    Alexander, James L.
    Ibraheim, Hajir
    Sheth, Bhavisha
    Little, Jessica
    Khan, Muhammad Saheb
    Richards, Camellia
    Hunter, Nikki
    Chauhan, Dharmisha
    Ratnakumaran, Raguprakash
    McHugh, Kathleen
    Pinato, David J.
    Nathan, Paul
    Choy, Julia
    Crusz, Shanthini M.
    Furness, Andrew
    Turajlic, Samra
    Pickering, Lisa
    Larkin, James
    Teare, Julian P.
    Papa, Sophie
    Speight, Ally
    Sharma, Anand
    Powell, Nick
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
  • [22] EFFICACY AND SAFETY OF ELECTIVE SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB: A MULTI-CENTRE COHORT STUDY
    Smith, Philip J.
    Storey, Daniel
    Gregg, Belle
    Critchley, Lisa
    Stenson, June
    Kneebone, Andrew
    Rimmer, Tracy
    Burke, Stevena
    Teoh, Wan Yi
    Vazeille, Stephan
    Serna, Solange
    Bond, Ashley
    Steel, Alan
    Dibb, Martyn
    Collins, Paul
    Derbyshire, Edmund
    Bodger, Keith
    Probert, Christopher
    Verma, Ajay
    Subramanian, Sreedhar
    GUT, 2021, 70 : A84 - A84
  • [23] Detecting treatment-by-centre interaction in multi-centre clinical trials
    Potthoff, RF
    Peterson, BL
    George, SL
    STATISTICS IN MEDICINE, 2001, 20 (02) : 193 - 213
  • [24] Efficacy and safety of tacrolimus in ulcerative colitis: a nationwide, multi-centre study from GETECCU
    Rodriguez-Lago, I.
    Castro-Poceiro, J.
    Fernandez-Clotet, A.
    Mesonero, F.
    Lopez-Sanroman, A.
    Lopez-Garcia, A.
    Marquez, L.
    Clos-Parals, A.
    Canete, F.
    Vicuna, M.
    Nantes, O.
    Merino, O.
    Matallana Royo, V.
    Gordillo, J.
    Elorza, A.
    Vicente, R.
    Casanova, M. J.
    Ferreiro-Iglesias, R.
    Perez-Galindo, P.
    Benitez, J. M.
    Taxonera, C.
    Garcia Garcia, M. J.
    Arranz, E. Martin
    Calafat, M.
    Martin-Cardona, A.
    Munoz Nunez, F.
    Miquel-Cusachs, J. O.
    Sainz Arnau, E.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S52 - S53
  • [25] A Retrospective Study of Treatment Options for Checkpoint-Inhibitor Colitis and Their Impact on Disease Outcomes
    Satila, Malek
    Rivera, Andres
    Abdul-Baki, Kian
    Lu, Linfeng
    Takigawa, Kei
    Cruz, Carolina Colli
    Menon, Raakhi
    Baerman, Elliot Axel
    Sullivan, Andrew
    Gupta, Tanvi
    Salim, Hamza
    Vemulapalli, Varun
    Lee, Irene J.
    Khan, Ayesha
    Natha, Cristina M.
    Varatharajalu, Krishnavathana
    Coleman, Garrett T.
    Zhao, Dan
    Thomas, Anusha
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S905 - S906
  • [26] How Many Doses of Infliximab Should Be Used in Immune Checkpoint Inhibitor-Induced Colitis? - A Retrospective Study
    Kundu, Rupayan
    Chatterjee, Arjun
    Zabor, Emily
    Isaacs, James
    Truong, Thach-Giao
    Sleiman, Joseph
    Funchain, Pauline
    Philpott, Jessica
    Kennedy, Lucy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S812 - S813
  • [27] Successful Treatment of Immune Checkpoint Inhibitor-Induced Diabetes With Infliximab
    Trinh, Beckey
    Donath, Marc Y.
    Laeubli, Heinz
    DIABETES CARE, 2019, 42 (09) : E153 - E154
  • [28] Outcomes Following Acute Severe Colitis at Initial Presentation: A Multi-centre, Prospective, Paediatric Cohort Study
    Dhaliwal, Jasbir
    Tertigas, Dominique
    Carman, Nicholas
    Lawrence, Sally
    Debruyn, Jennifer C.
    Wine, Eytan
    Church, Peter C.
    Huynh, Hien Q.
    Rashid, Mohsin
    El-Matary, Wael
    Deslandres, Colette
    Critch, Jeffrey
    Ricciuto, Amanda
    Carroll, Matthew W.
    Benchimol, Eric, I
    Muise, Aleixo
    Jacobson, Kevan
    Otley, Anthony R.
    Vallance, Bruce
    Mack, David R.
    Walters, Thomas D.
    Surette, Michael G.
    Griffiths, Anne M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (02): : 233 - 245
  • [29] A multi-centre audit of treatment and outcomes for older patients with glioblastoma
    Lorimer, C.
    Hanna, C.
    Chalmers, A.
    Saran, F.
    Brock, J.
    CLINICAL ONCOLOGY, 2017, 29 : S2 - S2
  • [30] Analysis of lesion localisation at colonoscopy: outcomes from a multi-centre UK study
    Moug, Susan J.
    Fountas, Spyridon
    Johnstone, Mark S.
    Bryce, Adam S.
    Renwick, Andrew
    Chisholm, Lindsey J.
    McCarthy, Kathryn
    Hung, Amy
    Diament, Robert H.
    McGregor, John R.
    Khine, Myo
    Saldanha, James D.
    Khan, Khurram
    Mackay, Graham
    Leitch, E. Fiona
    Mckee, Ruth F.
    Anderson, John H.
    Griffiths, Ben
    Horgan, Alan
    Lockwood, Sonia
    Bisset, Carly
    Molloy, Richard
    Vella, Mark
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2017, 31 (07): : 2959 - 2967
12345